ID
13642
Description
Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion; ODM derived from: https://clinicaltrials.gov/show/NCT01349491
Link
https://clinicaltrials.gov/show/NCT01349491
Keywords
Versions (1)
- 2/22/16 2/22/16 -
Uploaded on
February 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Atrial Fibrillation NCT01349491
Eligibility Atrial Fibrillation NCT01349491
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Anticoagulation contraindicated
Data type
boolean
Alias
- UMLS CUI [1]
- C1531588
Description
new york heart association class iv
Data type
boolean
Alias
- UMLS CUI [1]
- C1319796
Description
anti-arrhythmic drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0003195
Description
chronic kidney disease; Liver Dysfunction
Data type
boolean
Alias
- UMLS CUI [1]
- C1561643
- UMLS CUI [2]
- C0086565
Description
pregnant; lactating
Data type
boolean
Alias
- UMLS CUI [1]
- C2828358
- UMLS CUI [2]
- C0549206
Description
prolonged qt interval
Data type
boolean
Alias
- UMLS CUI [1]
- C0151878
Description
medication prolonged qt interval
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0151878
Description
ranolazine
Data type
boolean
Alias
- UMLS CUI [1]
- C0073633
Similar models
Eligibility Atrial Fibrillation NCT01349491
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C1113679 (UMLS CUI [2])
C0086565 (UMLS CUI [2])
C0549206 (UMLS CUI [2])
C0151878 (UMLS CUI [1,2])